These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7463959)

  • 21. The metabolic effects of tienilic acid, a new diuretic with uricosuric properties in man and dog.
    Lemieux G; Gougoux A; Vinay P; Kiss A; Baverel G
    Adv Exp Med Biol; 1977; 76B():334-41. PubMed ID: 16459
    [No Abstract]   [Full Text] [Related]  

  • 22. Ticrynafen, a uricosuric antihypertensive diuretic.
    Stote RM; Dubb JW; Familiar RG; Alexander F
    Clin Pharmacol Ther; 1978 Apr; 23(4):456-60. PubMed ID: 630794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihypertensive and biochemical effects of indacrinone enantiomers.
    Jain AK; Michael R; Ryan JR; McMahon FG
    Pharmacotherapy; 1984; 4(5):278-83. PubMed ID: 6504709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indacrinone: natriuretic and uricosuric effects of various ratios of its enantiomers in healthy men.
    Vlasses PH; Rotmensch HH; Swanson BN; Irvin JD; Johnson CL; Ferguson RK
    Pharmacotherapy; 1984; 4(5):272-7. PubMed ID: 6504708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Physiologic bases of the treatment of gout].
    Gascon J
    Union Med Can; 1976 Apr; 105(4):610-5. PubMed ID: 997014
    [No Abstract]   [Full Text] [Related]  

  • 26. Urate deposition disease. How is it regulated and how can it be modified?
    Klinenberg JR; Bluestone R; Schlosstein L; Waisman J; Whitehouse MW
    Ann Intern Med; 1973 Jan; 78(1):99-111. PubMed ID: 4682315
    [No Abstract]   [Full Text] [Related]  

  • 27. Ticrynafen: site of natriuretic activity.
    Stote RM; Dubb JW; Familiar R; Erb B; Weiherer S; Alexander F
    Nephron; 1979; 23 Suppl 1():25-32. PubMed ID: 471149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholecystography and nephrotoxicity.
    Swales JD; Mudge GH
    N Engl J Med; 1971 Aug; 285(6):354. PubMed ID: 4997050
    [No Abstract]   [Full Text] [Related]  

  • 29. Symposium on antihypertensive uricosuric diuretics. Montreal, June 17, 1978. A new class of renally active compounds with antihypertensive, diuretic, uricosuric properties.
    Nephron; 1979; 23 Suppl 1():1-66. PubMed ID: 471146
    [No Abstract]   [Full Text] [Related]  

  • 30. Metabolic effects in man of tienilic acid, a new diuretic with uricosuric properties.
    Lemieux G; Gougoux A; Vinay P; Kiss A; Baverel G
    Nephron; 1978; 20(1):54-64. PubMed ID: 619301
    [No Abstract]   [Full Text] [Related]  

  • 31. [Adverse effect of diuretics: hyperuricosuria].
    Kagami T
    Nihon Rinsho; 1984 Sep; 42(9):2105-10. PubMed ID: 6394806
    [No Abstract]   [Full Text] [Related]  

  • 32. Hypertension:risk factors and recent advances in treatment with tienilic acid. Proceedings of a symposium held at the Royal College of Physicians, London, on 22 and 23 May 1978.
    Postgrad Med J; 1979; 55 Suppl 3():1-135. PubMed ID: 504033
    [No Abstract]   [Full Text] [Related]  

  • 33. Control of uric acid excretion.
    Steele TH
    N Engl J Med; 1971 May; 284(21):1193-6. PubMed ID: 4929385
    [No Abstract]   [Full Text] [Related]  

  • 34. Uptake of uric acid by separated renal tubules of the rabbit. II. Effects of drugs.
    Kippen I; Nakata N; Honda S; Klinenberg JR
    J Pharmacol Exp Ther; 1977 Apr; 201(1):226-32. PubMed ID: 850142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new diuretic that does not reduce renal handling of uric acid in rats, S-8666.
    Yonetani Y; Iwaki K; Ishii M; Harada H
    Jpn J Pharmacol; 1987 Apr; 43(4):399-405. PubMed ID: 3613286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uricosuric effect of different doses of irtemazole in normouricaemic subjects.
    Gresser U; Kamilli I; Kronawitter U; Zöllner N
    Eur J Clin Pharmacol; 1990; 38(5):489-91. PubMed ID: 2379534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [2-PHENYL-5-BROMO-1,3-INDANEDIONE IN THE URICOSURIC TREATMENT OF GOUT AND URIC ACID DIATHESIS].
    PASERO G; RICCIONI N
    Clin Ter; 1963 Jul; 26():32-44. PubMed ID: 14050034
    [No Abstract]   [Full Text] [Related]  

  • 38. (1-oxo-2-substituted-5-indanyloxy)acetic acids, a new class of potent renal agents possessing both uricosuric and saluretic activity. A reexamination of the role of sulfhydryl binding in the mode of action of acylphenoxyacetic acidsaluretics.
    Cragoe EJ; Schultz EM; Schneeberg JD; Stokker GE; Woltersdorf OW; Fanelli GM; Watson LS
    J Med Chem; 1975 Feb; 18(2):225-8. PubMed ID: 1120997
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on the mechanism of ethambutol-induced hyperuricemia.
    Postlethwaite AE; Kelley WN
    Arthritis Rheum; 1972; 15(4):403-9. PubMed ID: 5046470
    [No Abstract]   [Full Text] [Related]  

  • 40. Symposium on antihypertensive uricosuric diuretics. Introduction.
    Lemieux G; Steele TH
    Nephron; 1979; 23 Suppl 1():1-2. PubMed ID: 471145
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.